Gene · 23462
Papers3,005
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,005
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting developmental vulnerabilities in childhood sarcomas. | Cancer Metastasis Rev | 2025 | 40983796 | PubTator, text mining | PubMed |
| Reversion of aortic valve cells calcification by activation of Notch signalling via histone acetylation induction. | Signal Transduct Target Ther | 2025 | 40962819 | PubTator, text mining | PubMed |
| Single-vessel transcriptome map pathological landscapes and reveal NR2F2-mediated smooth muscle cell phenotype acquisition in capillary malformations. | bioRxiv | 2025 | 40950147 | PubTator, text mining | PubMed |
| Bridging the gap of late-gestation nephrogenesis using a non-human primate model. | bioRxiv | 2025 | 40894529 | PubTator, text mining | PubMed |
| Multi-omic identification of perineurial hyperplasia and lipid-associated nerve macrophages in human polyneuropathies. | Nat Commun | 2025 | 40849297 | PubTator, text mining | PubMed |
| Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition. | Exp Hematol Oncol | 2025 | 40847323 | PubTator, text mining | PubMed |
| Identification of endothelial INSR as an osteosarcoma-related biomarker and therapeutic target based on weighted gene co-expression network analysis. | Discov Oncol | 2025 | 40846806 | PubTator, text mining | PubMed |
| Differential Expression of NOTCH Signaling Genes in Tissue Collected from Hidradenitis Suppurativa Patients. | J Burn Care Res | 2025 | 40817814 | PubTator, text mining | PubMed |
| AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells. | Front Immunol | 2025 | 40808939 | PubTator, text mining | PubMed |
| LIN28B hypomethylation drives oncogenic signaling and stratifies poor prognosis in juvenile myelomonocytic leukemia. | Transl Pediatr | 2025 | 40800176 | PubTator, text mining | PubMed |
| Boldine as a Potent Anticancer Agent: Induction of Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis via Inhibition of Notch Signaling in Human Oral Carcinoma Cells. | J Biochem Mol Toxicol | 2025 | 40760846 | PubTator, text mining | PubMed |
| A CD24+CD271+ melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance. | BMC Biol | 2025 | 40754577 | PubTator, text mining | PubMed |
| Carvedilol sensitizes paclitaxel-resistant gastric cancer AGS cells to paclitaxel: influences on apoptotic regulators, Notch, PI3K/AKT, ERK1/2 signaling pathways, and miR-34a expression. | Med Oncol | 2025 | 40736757 | PubTator, text mining | PubMed |
| AZD1080, a specific inhibitor of GSK‑3β, inhibits stemness and malignancies in osteosarcoma cancer stem‑like cells. | Mol Med Rep | 2025 | 40641129 | PubTator, text mining | PubMed |
| HEY1 promotes the development and metastasis of osteosarcoma through CD44/EGFR/FAK pathway. | J Cell Mol Med | 2025 | 40531089 | PubTator, text mining | PubMed |
| Insufficient expression of VTN promotes the development of early-onset severe preeclampsia through the HEY1/autophagy signaling pathway. | Placenta | 2025 | 40516241 | PubTator, text mining | PubMed |
| Azvudine Suppresses Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Targeting the Notch-HEY Signalling Pathway. | Int J Mol Sci | 2025 | 40507937 | PubTator, text mining | PubMed |
| Role of Estrogen Signaling in Notch Pathway Activation in Sertoli Cells. | Reprod Sci | 2025 | 40506655 | PubTator, text mining | PubMed |
| RBPJ/PAF1 Signaling Axis Promotes Cloning Expansion in Paroxysmal Nocturnal Hemoglobinuria Through NOTCH Signaling. | Int J Lab Hematol | 2025 | 40501337 | PubTator, text mining | PubMed |
| Machine learning algorithms integrate bulk and single-cell RNA data to reveal the crosstalk and heterogeneity of NOTCH and autophagy activity following idiopathic pulmonary fibrosis. | Int Immunopharmacol | 2025 | 40494203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23462/papers?page=4